4.3 Article

Clinical, dermoscopic, and histopathologic evaluation of topical methotrexate 1% hydrogel versus topical Calcipotriol 0.005% cream in the treatment of plaque psoriasis

Related references

Note: Only part of the references are listed.
Article Dermatology

Drug survival and predictor factors for discontinuation of methotrexate in psoriasis: a real-life multicenter study

Tugba Ozkok Akbulut et al.

Summary: This study evaluated drug survival for methotrexate (MTX) monotherapy in patients with plaque-type psoriasis. The average drug survival time was 15 months, with drug survival rates of 54.7%, 17.4%, and 8% after 1, 3, and 5 years, respectively. Adverse effects and ineffectiveness were the main reasons for drug discontinuation.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2021)

Article Soil Science

Biodegradable Hydrogels: Evaluation of Degradation as a Function of Synthesis Parameters and Environmental Conditions

Chiara Turioni et al.

Summary: This study describes biodegradable hydrogels made from cellulose, clay minerals, and humic acids, designed to protect, hydrate, and promote germination in soil. It also found that environmental factors in the soil play a more decisive role in the stability of these hydrogels than their synthesis parameters.

SOIL SYSTEMS (2021)

Review Medicine, General & Internal

Pathophysiology, Clinical Presentation, and Treatment of Psoriasis A Review

April W. Armstrong et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Dermatology

Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation

L. Gallo et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Article Dermatology

Rapid onset of action of calcipotriol/betamethasone dipropionate cutaneous foam in psoriasis, even in patients with more severe disease

A. E. Pink et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Article Dermatology

Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin

B. Dyring-Andersen et al.

BRITISH JOURNAL OF DERMATOLOGY (2014)

Article Pathology

Immunohistochemical study of osteopontin, Ki-67, and CD34 of psoriasis in Mansoura, Egypt

Maha Mohamed Amin et al.

INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2012)

Article Dermatology

The treatment of psoriasis vulgaris: 1% topical methotrexate gel

Buket Eskicirak et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)